CIK 0001348362
- Non-accelerated filer
- Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 202000871
- Phone
- +1 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Bhullar Baljinder Director | Grant or award · Stock Options | +11,000 | 11,000 | ||
| 2015-12-16 | Bhullar Baljinder CFO | Grant or award | +14,125 | 155,375 | ||
| 2015-09-21 | Bhullar Baljinder CFO | Other disposition · Warrants | −100,000 | $0.25 | $25K | 0 |
| 2014-12-23 | Bhullar Baljinder CFO | Grant or award · Stock Options | +50,000 | $0.10 | $5K | 852,500 |
| 2014-12-23 | Bhullar Baljinder CFO | Purchase · Stock Options | +500,000 | $0.11 | $55K | 1,075,000 |
| 2014-03-21 | Bhullar Baljinder CFO | Purchase | +100,000 | $0.12 | $12K | 100,000 |
| 2014-03-21 | Bhullar Baljinder CFO | Purchase · Warrants | +100,000 | $0.25 | $25K | 100,000 |
| 2013-06-18 | Bhullar Baljinder CFO | Grant or award · Stock Options | +17,500 | $0.09 | $2K | 302,500 |
| 2013-06-18 | Bhullar Baljinder CFO | Purchase · Stock Options | +175,000 | $0.10 | $18K | 175,000 |
| 2011-07-11 | Bhullar Baljinder CFO | Grant or award · Stock Options | +10,000 | $0.32 | $3K | 110,000 |
| 2010-01-01 | Bhullar Baljinder CFO | Other disposition · Stock Options | −300,000 | $0.20 | $60K | 0 |
Page 1 of 1 · 11 trades